The Turkish Lira’s Comeback Slams Into Emerging Market Weakness

When I last wrote about the Turkish lira in mid-January, USD/TRY had pulled back sharply off a parabolic run-up. The iShares MSCI Turkey (TUR) was also at the beginning of a dramatic bottoming pattern that was later confirmed with a close above its 50-day moving average (DMA). Source: FreeStockCharts.com When the Central Bank of the … Read more

U.S. Dollar Weakness Dominating the Canadian Dollar Trade

The U.S. dollar index (DXY0) has started 2017 on a notable losing streak. The index’s clean close today below 100 is the latest confirmation of that weakness. The U.S. dollar index continued its dribbling down the lower part of Bollinger Bands (BBs) that define the current downtrend. Source: StockCharts.com This extension of weakness has complicated … Read more

T2108 Update (January 20, 2017) – Looking Past the S&P 500’s Post-Inauguration Yawn

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

T2108 Update (December 30, 2016) – From a Roar to Caution: The S&P 500 Tentatively Steps Toward 2017

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

T2108 Update (November 7, 2016) – Almost As Bullish As A Relief Rally Can Get

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

T2108 Update (November 1, 2016) – Divergences Confirmed: Stock Market Sags to the Edge of Oversold

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

T2108 Update (October 28, 2016) – Divergences Weigh Further on the Stock Market

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

T2108 Update (October 19, 2016) – The S&P 500 Bounces Weakly from Near-Oversold

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

The Brazil ETF Continues Adding to A Tremendous 2016 Rally

Almost two months ago, I explained my decision to sell my position in iShares MSCI Brazil Capped (EWZ). I also pointed to a 20% correction as the next time I will consider buying again. Since then, EWZ rallied, dipped slightly to a lower low, and then resumed its current rally. That rally accelerated a bit … Read more

A Fresh Breakdown for iShares Nasdaq Biotechnology (IBB)

Drug corporations' greed is unbelievable. Ariad has raised the price of a leukemia drug to almost $199,000 a year. https://t.co/EB4nEPxP2G — Bernie Sanders (@SenSanders) October 14, 2016 The drug industry is getting very, very nervous. We are going to take them on and lower the cost of medication across this country. https://t.co/6PeiLJnR0F — Bernie Sanders … Read more